ACE2 (Angiotensin-Converting Enzyme 2)-Mediated Protection From Pulmonary Hypertension: Lung-Gut Axis at Center Stage

Hypertension. 2020 Jul;76(1):28-29. doi: 10.1161/HYPERTENSIONAHA.120.15175. Epub 2020 Jun 10.

Authors

Mahmoud Gheblawi^{1

2}, Kaiming Wang^{3

2}, Gavin Y Oudit^{1

3

2}

Affiliations

¹ From the Department of Physiology (M.G., G.Y.O.), University of Alberta, Edmonton, Canada.
² Mazankowski Alberta Heart Institute (M.G., K.W., G.Y.O.), University of Alberta, Edmonton, Canada.
³ Division of Cardiology, Department of Medicine (K.W., G.Y.O.), University of Alberta, Edmonton, Canada.

PMID: 32520621
DOI: 10.1161/HYPERTENSIONAHA.120.15175

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Angiotensin I
Angiotensin-Converting Enzyme 2*
Gastrointestinal Microbiome*
Humans
Hypertension, Pulmonary* / prevention & control
Hypoxia
Lung

Substances

Angiotensin I
Angiotensin-Converting Enzyme 2

Grants and funding

CIHR/Canada